InvestorsHub Logo
Followers 12
Posts 1031
Boards Moderated 0
Alias Born 02/26/2002

Re: None

Tuesday, 01/28/2014 11:23:35 AM

Tuesday, January 28, 2014 11:23:35 AM

Post# of 1980
WHEN WILL THEY APPROACH THE FDA????? with the results obtained with the automated VIDAS Galectin-3 assay in this clinical research study," said Dr. Paul R. Sohmer, President and CEO of BG Medicine, Inc. "These results support commercialization of the VIDAS Galectin-3 assay in Europe and substantiate our efforts to assist bioMerieux with its pursuit of 510(k) clearance of the assay in the U.S." WHEN????????????